PHIO PHARMACEUTICALS CORP

Historical 13F Holders

Symbol
PHIO
CUSIP
71880W501
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 71880W501 since 12/18/2024, newest first.

Filer % of Class Filed
CVI Investments, Inc. 13G/A Amendment 1
9.9% 2/17/2026
Event 12/31/2025
Intracoastal Capital LLC 13G/A Amendment 2
9.1% 2/13/2026
Event 12/31/2025
Orca Capital AG 13G/A Amendment 5 4.9% 12/11/2025
Event 12/8/2025
Orca Capital AG 13G/A Amendment 4 6.5% 11/24/2025
Event 11/20/2025
Orca Capital AG 13G/A Amendment 3 4.9% 11/12/2025
Event 11/7/2025
CVI Investments, Inc. 13G
9.9% 11/10/2025
Event 11/3/2025
Intracoastal Capital LLC 13G/A Amendment 1
7.0% 11/7/2025
Event 9/30/2025
Orca Capital AG 13G/A Amendment 2 9.8% 11/6/2025
Event 11/3/2025
Orca Capital AG 13G/A Amendment 1 4.9% 8/7/2025
Event 8/4/2025
CVI Investments, Inc. 13G/A Amendment 1
4.9% 2/7/2025
Event 12/31/2024
Orca Capital AG 13G 9.9% 1/23/2025
Event 12/19/2024
Intracoastal Capital LLC 13G
10.0% 1/17/2025
Event 1/13/2025
Intracoastal Capital LLC 13G
4.99% 12/27/2024
Event 12/19/2024
CVI Investments, Inc. 13G
7.3% 12/26/2024
Event 12/19/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 6 14.5 k $14.9 k
2026 Q2 24 647 k $663 k
2026 Q1 24 668 k $815 k
2025 Q4 17 364 k $382 k
2025 Q3 11 188 k $467 k
2025 Q2 12 168 k $395 k
2025 Q1 12 101 k $131 k
2024 Q4 12 154 k $277 k
2024 Q3 7 28.5 k $98.3 k